Stocks and Investing Stocks and Investing
Wed, July 29, 2015
Tue, July 28, 2015
Mon, July 27, 2015

Aaron Gal Upgraded (BIIB) to Buy and Decreased Target to $385 on, Jul 27th, 2015


Published on 2024-10-25 09:28:33 - WOPRAI, Aaron Gal
  Print publication without navigation


Aaron Gal of Bernstein, Upgraded "Biogen Inc." (BIIB) to Buy and Decreased Target from $436 to $385 on, Jul 27th, 2015.

Aaron has made no other calls on BIIB in the last 4 months.



There are 4 other peers that have a rating on BIIB. Out of the 4 peers that are also analyzing BIIB, 3 agree with Aaron's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $410 on, Wednesday, July 22nd, 2015
  • Jay Olson of "Oppenheimer" Initiated at Hold on, Monday, April 27th, 2015
  • Christopher Marai of "Nomura" Maintained at Hold with Increased Target to $442 on, Monday, April 27th, 2015


This is the rating of the analyst that currently disagrees with Aaron


  • Geoffrey Porges of "Leerink Swann" Maintained at Buy with Decreased Target to $512 on, Thursday, June 11th, 2015

Contributing Sources